Format

Send to

Choose Destination
Schizophr Res. 2016 Apr;172(1-3):211-2. doi: 10.1016/j.schres.2016.01.056. Epub 2016 Feb 11.

Cannabis-induced psychosis associated with high potency "wax dabs".

Author information

1
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California; Department of Veterans Affairs, VA Greater Los Angeles Healthcare System, Los Angeles, CA. Electronic address: joseph.pierre2@va.gov.
2
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California.
3
College of Medicine, University of Vermont, Burlington, VT.

Abstract

With mounting evidence that the risk of cannabis-induced psychosis may be related to both dose and potency of tetrahydrocannbinol (THC), increasing reports of psychosis associated with cannabinoids containing greater amounts of THC are anticipated. We report two cases of emergent psychosis after using a concentrated THC extract known as cannabis "wax," "oil," or "dabs" raising serious concerns about its psychotic liability. Although "dabbing" with cannabis wax is becoming increasingly popular in the US for both recreational and "medicinal" intentions, our cases raise serious concerns about its psychotic liability and highlight the importance of understanding this risk by physicians recommending cannabinoids for purported medicinal purposes.

KEYWORDS:

Cannabis; Cannabis oil; Cannabis wax; Cannabis-induced psychosis, catatonia; Marijuana; Tetrahydrocannabinol

PMID:
26876313
DOI:
10.1016/j.schres.2016.01.056
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center